NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 5BSF designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5BSF_NAD_I_301 | 59% | 22% | 0.097 | 0.923 | 1.6 | 1.64 | 8 | 18 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_B_301 | 57% | 20% | 0.101 | 0.919 | 1.73 | 1.64 | 14 | 13 | 0 | 0 | 100% | 1 |
| 5BSF_NAD_F_301 | 53% | 19% | 0.103 | 0.904 | 1.84 | 1.59 | 13 | 13 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_A_301 | 53% | 21% | 0.103 | 0.903 | 1.67 | 1.61 | 11 | 11 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_H_301 | 48% | 19% | 0.107 | 0.887 | 1.85 | 1.57 | 11 | 13 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_C_301 | 47% | 20% | 0.113 | 0.892 | 1.65 | 1.68 | 11 | 17 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_J_301 | 44% | 17% | 0.117 | 0.88 | 1.79 | 1.75 | 11 | 15 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_E_301 | 42% | 19% | 0.119 | 0.877 | 1.72 | 1.66 | 9 | 13 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_D_301 | 37% | 17% | 0.126 | 0.86 | 1.74 | 1.77 | 10 | 15 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_G_301 | 20% | 18% | 0.145 | 0.794 | 1.79 | 1.66 | 12 | 13 | 1 | 0 | 100% | 1 |
| 1DBV_NAD_O_336 | 100% | 19% | 0.012 | 0.999 | 1.39 | 1.98 | 5 | 12 | 0 | 0 | 100% | 1 |
| 1OWB_NAD_A_3000 | 100% | 7% | 0.015 | 0.998 | 2.36 | 2.37 | 10 | 13 | 1 | 0 | 100% | 1 |
| 9QJ0_NAD_A_501 | 100% | 84% | 0.015 | 0.998 | 0.35 | 0.36 | - | - | 2 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 19% | 0.016 | 0.998 | 1.58 | 1.84 | 4 | 15 | 0 | 0 | 100% | 1 |
| 3UVE_NAD_B_300 | 100% | 29% | 0.016 | 0.998 | 1.2 | 1.63 | 4 | 14 | 0 | 0 | 100% | 1 |














